Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy

Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy

BackgroundThe persistence of residual tumour after neoadjuvant chemotherapy (NAC) in localised triple-negative breast cancer (TNBC) is known to have a negative prognostic value. However, different degrees of expression of some immunohistochemical markers may correlate with different prognoses.Method...

Full description

Bibliographic Details
Main Authors: Silvia Mihaela Ilie, Nathalie Briot, Guillaume Constatin, Alis Ilie, Francoise Beltjens, Sylvain Ladoire, Isabelle Desmoulins, Audrey Hennequin, Aurelie Bertaut, Charles Coutant, Sylvain Causeret, Niama Ghozali, Bruno Coudert, Laurent Arnould
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
neoadjuvant chemotherapy
residual disease
triple-negative breast cancer
prognostic biomarkers
immunohistochemical marker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1309890/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1309890/full

Similar Items